Review of Postmortem Clinical Genetic Testing Sample Success Rates and Payors from Commercial Labs

Heather MacLeod, Samantha Baxter, Melissa Kelly(Geisinger Health System), Amanda Singleton, Justin Leighton, Kate D. Lynch(Royal Adelaide Hospital), Jill S. Dolinsky(Ambry Genetics (United States))

Unknown

January 1, 2013

Cited by 0

Related Papers

Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>

|JNCI Journal of the National Cancer Institute|2020|163

Obeticholic acid—a new therapy in PBC and NASH

|British Medical Bulletin|2020|123

Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System

|Hepatology|2018|106

Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases

|Clinical Gastroenterology and Hepatology|2019|104

Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis

|Journal of Crohn s and Colitis|2020|55